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Abstract 12 
Mixtures of two cationic proteins were used to prepare protein-DNA gel particles, employing 13 
associative phase separation and interfacial diffusion (Morán et al., 2009a). By mixing the two 14 
proteins, we have obtained particles that displayed higher loading efficiency and loading capacity 15 
values than those obtained in single-protein systems. However, nothing is known about the 16 
adverse effects on haemocompatibility and cytotoxicity of these protein-DNA gel particles. Here, 17 
we examined the interaction of protein-DNA gel particles obtained by two different preparation 18 
methods, and their components, with red blood cells and established cells. From a haemolytic 19 
point of view, these protein-DNA gel particles were demonstrated to be promising long-term blood-20 
contacting medical devices. Safety evaluation with the established cell lines revealed that, in 21 
comparison with proteins in solution, the cytotoxicity was reduced when administered in the 22 
protein-DNA systems. In comparison with large-sized particles, the cytotoxic responses of small-23 
sized protein-DNA gel particles showed to be strongly dependent of both the protein composition 24 
and the cell line being the tumour cell line HeLa more sensitive to the deleterious effects of the 25 
mixed protein-based particles. The observed trends in haemolysis and cell viabilities were in 26 
agreement with the degree of complexation values obtained for the protein-DNA gel particles 27 
prepared by both preparation methods.  28 
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1. Introduction 34 
 35 
A general understanding of the interactions between DNA and oppositely charged agents, and in 36 
particular of phase behaviour, has provided a basis for developing novel, DNA-based materials, 37 
including gels, membranes and gel particles (Costa et al., 2008; Lindman et al. 2009, Lindman et 38 
al., 2010) We prepared novel DNA gel particles employing associative phase separation and 39 
interfacial diffusion. By mixing solutions of DNA (either single- (ssDNA) or double-stranded 40 
(dsDNA)) with solutions of different cationic agents, such as surfactants, proteins and 41 
polysaccharides, the possibility of forming DNA gel particles without adding any kind of cross-linker 42 
or organic solvent has been confirmed (Morán et al, 2010, Morán et al., 2013 and references 43 
therein).  44 
A novel nonviral vector for gene therapy is recognised as successful if it is biocompatible, capable 45 
of interacting with DNA, able to form sufficiently small particles which can be formulated 46 
reproducibly, endocytosed, able to protect the complexed DNA from degradation during transport, 47 
and capable of delivering DNA to the target tissue in sufficient quantity (Ledley, 1996; Pack et al., 48 
2000; Davis, 2002). 49 
Among the different cationic agents studied, the cationic surfactants offered particularly efficient 50 
control of the properties of these DNA-based particles (Morán et al., 2007a; Morán et al., 2007b) 51 
However, the cytotoxicity of quaternary ammonium surfactants is well known (Lasic, 1997). 52 
Proteins as the matrices for drug delivery particles have many advantages including 53 
biodegradability, biocompatibility, and amenability to surface modification (Kratz, 2008). Drug 54 
carriers using albumin as matrices for the delivery of small molecule drugs and biological cargos, 55 
such as plasmid DNA and siRNA, are being previously studied (Rhaese et al., 2003; Hawkins et 56 
al., 2008; Abbasi et al., 2011).  However, in all cases, the presence of cationic polyelectrolytes is 57 













needed to condense the nucleic acids to efficiently mediate gene transfer (Rhaese et al., 2003; 58 
Abbasi et al., 2011).  59 
DNA gel particles have been prepared using the cationic functionality of a cationic protein. 60 
Lysozyme has been used as carrier to form DNA gel particles by interfacial diffusion (Morán et al., 61 
2007a) The obtained particles, however, were not able to protect the secondary structure of the 62 
condensed DNA and an important burst release stage was observed when the kinetics of DNA 63 
release from these protein-DNA gel particles were determined. In a recent study, two cationic 64 
proteins, lysozyme and protamine sulphate, were used as biocompatible carriers to form DNA gel 65 
particles by interfacial diffusion (Morán et al., 2009a). The particles were characterised with respect 66 
to the degree of DNA entrapment, swelling and dissolution behaviour, surface morphology, 67 
secondary structure of DNA in the particles and kinetics of DNA release, and the study 68 
demonstrated that DNA was effectively entrapped in the mixed protein solutions, protecting its 69 
secondary structure. A significant increase in the degree of effective entrapment of DNA was 70 
achieved by mixing the two proteins. The magnitude of DNA release was controlled and controlled 71 
release systems were achieved by changing the lysozyme/protamine ratio in the protein solution 72 
where particles were formed.  73 
At a consensus conference of the European Society for Biomaterials in 1986, the word 74 
“biocompatibility” was defined as “the ability of a material to perform with an appropriate host 75 
response in a specific application”.  With the rapid development of biomaterials, the scope of 76 
“biocompatibility” has been widely broadened. On the basis of designing DNA gel particles for 77 
therapeutic purposes, we use biocompatibility to include the deleterious effects caused by the DNA 78 
gel particles, covering the in vitro haemolytic and cytotoxic assessments. Currently, nothing is 79 
known about the adverse effects on biocompatibility of these protein-DNA gel particles. One 80 
drawback of these DNA gel particles, in toxicological terms, is the need for a cationic compound, 81 
which may cause some cellular damage. A recent study (Morán et al., 2012) indicate, however, 82 
that the effect of the cationic surfactants can be modulated when administered in the DNA gel 83 
particles, unlike what happens in aqueous solution. This modulation is due to the strong interaction 84 













between the surfactant and the biopolymer, which leads to a very slow release of the surfactant 85 
from the vehicle. 86 
Safety evaluation of new products or ingredients destined for human use is crucial prior to 87 
exposure. Therefore, rapid, sensitive and reliable bioassays are required in order to examine the 88 
toxicity of these substances. Established cell lines are useful alternative test systems for 89 
toxicological studies of this kind (Crespi, 1995); however, they must be chosen with care with 90 
regard to their origin (Jondeau, et al., 2006). Moreover, cytotoxicity assays are among the most 91 
common in vitro endpoints used to predict the potential toxicity of a substance in a cell culture 92 
(Martínez et al., 2006). The size of particles plays an important role regarding in vitro and in vivo 93 
applications. Even particles of the same material can show completely different behaviour due to, 94 
for example, slight differences in surface coating, charge or size. The particle size determines the 95 
efficiency of cellular uptake and subsequent intracellular processing (Rejman et al., 2004).  96 
Nano-sized materials have a high potential in technical and medical applications provided they are 97 
not toxic. Despite the significant scientific interest and promising potential, the safety of 98 
nanoparticulate systems remains a growing concern, considering that biological applications of 99 
nanoparticles could lead to unpredictable effects. The prediction of toxicity is difficult, but 100 
cytotoxicity screening, which is routinely used in drug screening, gives a good indication of 101 
potential adverse effects in cells. As a general rule, nano-sized materials show higher reactivity 102 
than bulk materials of the same composition. Size, surface charge, and hydrophobicity interact in 103 
complex ways and have a pronounced influence on biocompatibility. Aggregation in physiological 104 
fluids is often observed. Therefore, toxicity data must be interpreted in the context of the 105 
physicochemical characteristics of the nano-sized materials (Fröhlich et al., 2012). 106 
Currently, there are no specific testing requirements for nanotechnology products, and therefore, 107 
researchers took liberal approaches to studying toxicity (Boverhof and David, 2010; Robbens et al., 108 
2010). Moreover, it is worth noting that, because of the expense of animal testing in  toxicology and 109 
pressure from both the general public and government to develop alternatives to in vivo testing, in 110 













vitro cell-based models may be more attractive for preliminary testing of nanomaterials (Hillegass 111 
et al. 2009). 112 
In this context, the purpose of the present study was to prepare and characterise the 113 
haemocompatibility of and cytotoxicity response to protein-DNA gel particles formed by mixing 114 
double-stranded DNA (dsDNA) with lysozyme/protamine sulphate mixtures using two different 115 
approaches. The interaction of these protein-DNA gel particles and their components with 116 
erythrocytes, non-tumour (3T3 fibroblast) and tumour (HeLa) cell lines is described, using the 117 
imposed variations in protein composition and the size of the final particles, as a consequence of 118 
the different preparation method, as controlling parameters.  119 
2. Experimental section 120 
2.1. Materials 121 
The sodium salt of deoxyribonucleic acid (DNA) from salmon testes with an average degree of 122 
polymerisation of ≈2000 base pairs (bp) was purchased from Sigma and used as received. The 123 
DNA concentrations were determined spectrophotometrically, assuming that for an absorbance of 124 
1 at 260 nm, a solution of dsDNA has a concentration of 50 μg mL-1 (Sambrook et al., 1889). All 125 
DNA concentrations are given in molarity per phosphate group, i.e., molarity per negative charge. 126 
The absorbance ratios at 260 and 280 nm of the stock solutions were found to be between 1.8 and 127 
1.9, which suggested the absence of proteins (Saenger, 1984). Lysozyme from chicken egg white 128 
(LS), with a molecular mass of 14.3 kDa, protamine from salmon in the sulphate salt (PS), with a 129 
molecular mass of 5.1 kDa, and Tris base were purchased from Sigma and used as received. 130 
N,N,N',N'-tetramethylacridine-3,6-diamine (acridine orange (AO)) was supplied by Molecular 131 
Probes (Invitrogen).  132 
 133 
2.2. Particle Preparation 134 













The dsDNA stock solutions were prepared in 10 mM NaBr to stabilise the DNA secondary structure 135 
in its native B-form conformation. LS, PS, or mixtures of both were dissolved in a PBS buffer (pH 136 
7.4). Table 1 summarises the composition of the protein systems studied.  137 
[Table 1 here] 138 
2.2.1. Protein-DNA gel particles prepared by the dropwise addition method 139 
Particles were prepared at a DNA and protein system ratio equal to 1, R= [DNA]/[P+], where [P+] is 140 
the concentration of the corresponding protein system (concentrations determined per charge). In 141 
all cases, [DNA] was equal to 60 mM. DNA solutions were added dropwise via a 22-gauge needle 142 
into gently agitated protein solutions (2 mL). Under optimal conditions, droplets from DNA solutions 143 
instantaneously gelled into discrete particles upon contact with the protein solution. Thereafter, the 144 
particles were equilibrated in the solutions for a period of 2 h at room temperature. After this 145 
period, the particles formed were separated by filtration through a G2 filter and washed with 5 x 8 146 
mL PBS to remove excess salt. 147 
2.2.2. Protein-DNA gel particles prepared by the nebulisation method 148 
Particles were prepared at a DNA and protein system ratio equal to 1. In this case, [DNA] was 149 
equal to 2.5 mM. Higher concentrations of DNA produced high-viscosity solutions, rendering them 150 
inconvenient systems for the nebulisation process. The Comp Air NE-28-E nebuliser (Omrom) 151 
employed enabled the generation of very fine droplets/aerosols with a MMAD (Mass Median 152 
Aerodynamic Diameter) of 2.8 µm for NaF solution, independently measured at SolAero Ltd, 153 
Canada, by Dr John Dennis, according to EN 13544–1.  DNA solutions were nebulised and added 154 
to gently agitated protein solutions (5 mL).  155 
 156 
2.3. Interaction with Erythrocytes 157 
2.3.1. Preparation of red blood cell suspensions  158 
Rat blood was obtained from anaesthetised animals by cardiac puncture and drawn into tubes 159 
containing EDTA. This procedure was approved by the Ethical Committee for Animal Research of 160 













the University of Barcelona. Serum was removed from the blood by centrifugation at 3,000 rpm 161 
(Megafuge 2.0 R Heraeus Instruments) at 4 º C for 10 min, and subsequent suction. The red blood 162 
cells were then washed three times at 4 º C by centrifugation at 3,000 rpm with isotonic saline PBS 163 
solution, containing 22.2 mmol L-1 Na2HPO4, 5.6 mmol L
-1 KH2PO4, 123.3 mmol L
-1 NaCl in distilled 164 
water (pH 7.4). Following the last wash, the cells were diluted to ½ of their volume with isotonic 165 
phosphate buffer solution (PBS) (cell density of 8 x 109 cell mL-1). 166 
2.3.2. Haemolysis assay 167 
The membrane-lytic activity of the systems was examined by haemolysis assay. Firstly, haemolytic 168 
response to the different proteins in solution was tested. Thus, a series of different volumes of 169 
protein solution (10 mg mL-1 in PBS), ranging from 10 to 200 μL, were placed in polystyrene tubes 170 
and an aliquot of 25 μL of the erythrocyte suspension was added to each tube. The final volume 171 
was 1 mL. The tubes were incubated at room temperature for 10 min under shaking conditions. 172 
Following incubation, the tubes were centrifuged (5 min at 10, 000 rpm). The degree of haemolysis 173 
was determined by comparing absorbance (540 nm) (Shimadzu UV-160A) of the supernatant with 174 
that of the control samples totally haemolysed with distilled water. Positive and negative controls 175 
were obtained by adding an aliquot of 25 µL of erythrocyte suspension to distilled water and 176 
isotonic PBS solution, respectively. 177 
In the case of the protein-DNA systems, two kinds of experiments were carried out. Either the 178 
individual protein-DNA gel particles (dropwise addition method) or the dispersions containing the 179 
protein-DNA gel particles (nebulisation method) or the protein solutions that were used to prepare 180 
the corresponding protein-DNA gel particles were studied. In the case of protein-DNA particles 181 
obtained by the dropwise addition method, individual DNA gel particles were placed in the tubes. In 182 
the case of dispersions containing the protein-DNA gel particles obtained by the nebulisation 183 
method (100, 200 or 300 μL of the corresponding solution) or the protein solutions prior to the 184 
preparation of the corresponding protein-DNA gel particles (25 μL of the corresponding solution) 185 
were added to each tube. In all cases, an aliquot of 25 μL of erythrocyte suspension was added to 186 













each tube. The final volume was 1 mL. The tubes were incubated at room temperature for different 187 
times (10-360 min) under shaking conditions. At the same defined times, the incubated samples 188 
were centrifuged (5 min at 10, 000 rpm). The degree of haemolysis was determined following the 189 
same procedure as described above.  190 
The correlation between the erythrocyte population and the haemolytic response in the presence of 191 
the particles was established by counting the number of erythrocytes on each sample using a 192 
Bürker-Türk counting chamber, covered by a cover slip and analyzed by a contrast microscope 193 
(Olympus BX41). Simultaneously with the counting of the erythrocytes on each sample, studies of 194 
erythrocyte agglutination were carried out.  195 
2.3.3. DNA release 196 
Simultaneously with the haemolysis assay experiments, DNA release from the protein-DNA gel 197 
particles was determined. To this end, individual DNA gel particles were placed in the tubes and 198 
isotonic PBS solution was added to a final volume of 1 mL. The tubes were incubated at room 199 
temperature for the same defined times as in the case of the haemolysis assay experiments, under 200 
shaking conditions. The concentration of dsDNA released into the supernatants was determined by 201 
using the NanoPhotometerTM (Implen.) 202 
2.3.4. Protein release 203 
Furthermore, protein release from the protein-DNA gel particles was determined. To this end, 204 
individual DNA gel particles were placed in the tubes and isotonic PBS solution was added to a 205 
final volume of 1 mL. The tubes were incubated at room temperature for the same defined times as 206 
in the case of the haemolysis assay experiments, under shaking conditions. Following incubation, 207 
the concentration of solubilised protein in the supernatants was determined using the Bio-Rad 208 
Protein Assay, based on the method described by Bradford (Bradford, 1986). This involves the 209 
addition of an acidic dye to the protein solution and subsequent measurement at 595 nm with a 210 
spectrophotometer. Comparison with a standard curve provides a relative measurement of protein 211 
concentration. 212 













2.4. Cell culture 213 
The murine Swiss albino 3T3 fibroblast cell line and the human epithelial carcinoma HeLa cell line 214 
were grown in DMEM medium (4.5 g L-1 glucose) supplemented with 10% (v/v) FBS, 2 mM L-215 
glutamine, 100 U mL-1 penicillin and 100 μg mL-1 streptomycin at 37ºC, 5% CO2. The 3T3 and 216 
HeLa cells were routinely cultured in 75 cm2 culture flasks and were trypsinised using trypsin-217 
EDTA when the cells reached approximately 80% confluence. 218 
2.4.1.Cytotoxicity assays 219 
The cytotoxic effect of the systems was measured by tetrazolium salt MTT assay (Mosmann, 220 
1983). 3T3 and HeLa cells were seeded into the central 60 wells of a 96-well plate at a density of 1 221 
x 105 and 5 x 104 cells mL-1, respectively. After incubation for 24 h under 5% CO2 at 37ºC, the 222 
spent medium was replaced in the wells with 100 μL of fresh medium supplemented with 5% FBS 223 
containing protein solution at the required concentration range (50-2000 μg mL-1). 224 
In the case of the protein-DNA systems, two kinds of studies were carried out. Either the individual 225 
protein-DNA gel particles (dropwise addition method) or the dispersions containing the protein-226 
DNA gel particles (nebulisation method) or the protein solutions that were used to prepare the 227 
corresponding protein-DNA gel particles were studied. In the case of the individual protein-DNA gel 228 
particles, 100 μL of fresh medium supplemented with 5% FBS was added in each well, and then 229 
individual DNA gel particles were placed in them. In the case of the dispersion containing the 230 
protein-DNA gel particles or th  protein solutions prior to the preparation of the corresponding 231 
protein-DNA gel particles, 100 μL of each system diluted 1:1 in fresh medium supplemented with 232 
5% FBS was placed in each well. 233 
In all cases, after 24 h, the protein-DNA gel particles or the protein-containing medium were 234 
removed and 100 μL of MTT in PBS (5 mg mL-1) diluted 1:10 in medium without FBS and phenol 235 
red was then added to the cells. The plates were incubated for a further 3 h, after which the 236 
medium was removed, and the cells were washed once in PBS. Thereafter, 100 μL of DMSO was 237 
added to each well to dissolve the purple formazan product. After 10 min on a microtitre-plate 238 













shaker at room temperature, absorbance of the resulting solutions was measured at 550 nm using 239 
a Bio-Rad 550 microplate reader. The effect of each treatment was calculated as a percentage of 240 
cell viability inhibition against the respective controls. 241 
2.5. Internalisation of AO-labeled PS-DNA gel particles 242 
2.5.1. Preparation of AO-labeled PS-DNA gel particle dispersion  243 
AO stock solution (10 µg mL-1) was diluted 1:5 in a solution of DNA (2.5 mM). The AO-labeled PS-244 
DNA gel particle dispersion was prepared by nebulisation of the AO-labeled DNA into a solution of 245 
protein (2.5 mM). After formation, the particle dispersion was filtered by a centrifugal concentrator 246 
(cut-off 3,000 MWCO, Vivaspin 2) to remove the excess of free PS and non-incorporated AO. 247 
2.5.2. Cellular uptake experiments 248 
HeLa cells (5 x 104 cells mL-1) were seeded into 24-well tissue plates on Corning´s circular glass 249 
cover-slips at 37ºC and 5% CO2 atmosphere. After incubation for 24h, the purified AO-labeled PS-250 
DNA gel particle dispersion was diluted 1:1 in medium without FBS and phenol red and then added 251 
to the cells. Untreated cells stained with AO (1.5 µg mL-1) in DMEM medium without FBS and 252 
phenol red were used as a cell control. The plates were incubated for a further 2 h at 37ºC and 5% 253 
CO2 atmosphere, after which the medium was removed, and the cells were washed four times with 254 
sterile PBS. After the final wash, the cells were fixed with 4% (v/v) paraformaldehyde in PBS  for 255 
15 min at room temperature and were washed twice with PBS.  256 
Individual cover-slips were then mounted on clean glass slides with Prolong® Gold antifade 257 
reagent (Invitrogen). Both contrast and fluorescence images were acquired with a Olympus BX41 258 
microscope equipped with a UV-mercury lamp (100W Ushio Olympus) and a filter set type MNIBA3 259 
(470-495 nm excitation and 505 nm dichromatic mirror) Images were digitised on a computer 260 
through a video camera (Olympus digital camera XC50) and were analysed with an image 261 
processor (Cell B analysis).  262 
3. Results   263 













3.1. Haemolytic assessments 264 
3.1.1. Haemolysis induced by proteins in solution 265 
The haemolytic activity of both proteins at different pH was determined according to concentration. 266 
In these experiments, haemolysis was determined at a fixed time (after 10 min of incubation) in the 267 
presence of protein concentrations in the range of 100 to 2000 µg mL-1. The haemolysis assay 268 
showed that both proteins were non-haemolytic in nature. The haemolytic potential of a material is 269 
defined as the measure of the extent of haemolysis that may be caused by the system when it 270 
comes into contact with blood. At pH 7.4, both proteins were found to be non-haemolytic, the 271 
extent of haemolysis being lower than the permissible level of 5% (Rao et Sharma, 1997; Lv et al., 272 
2007; He et al., 2009; Verkatesan et al., 2011). For the lowest concentration, the maximum 273 
haemolysis values were 0.3% and 0.8% for the LS and PS proteins, respectively. At the highest 274 
concentration, the value increased to 0.5% in the case of LS, and 1.7% in the case of PS. In both 275 
cases, haemolysis was negligible at the highest concentration assayed (2000 µg mL-1).  276 
No significant differences were observed in the haemolytic response when varying the pH of the 277 
buffer solution from 7.4 to 5.4. The isoelectric point (pI) value of the LS and PS proteins was 278 
almost equal to 11 and 12, respectively, conserving their cationic character under the studied pH 279 
interval. Although results on pH dependence of LS net charges demonstrated that the charges 280 
varied between +8.5 at pH 5.5 to +7 at pH 8 (Desfougères, et al., 2010), there was no strong 281 
alteration in the haemolytic responses. To the author's knowledge, nothing has been reported on 282 
pH dependence of PS net charges.  283 
The observed behaviour differed strongly from that observed, for instance, for surfactants in 284 
solution (Morán et al., 2012). In this kind of system, haemolysis varied with the surfactant 285 
concentration in a sigmoidal manner, until reaching total haemolysis. 286 
3.1.2 Haemolysis induced by protein-DNA gel particles 287 
3.1.2.1. Protein-DNA gel particles prepared by the dropwise addition method 288 













In order to evaluate the effect of protein-DNA complexation on the corresponding haemolytic 289 
response, both the corresponding protein-DNA gel particles as well as the protein solutions at the 290 
conditions used to prepare the protein-DNA gel particles,  were incubated with the erythrocyte 291 
suspensions for different lengths of time (ranging from 10 to 360 min) (Fig. 1). Using this approach, 292 
the haemolytic response to the protein solutions corresponding to the conditions used to prepare 293 
the protein-DNA gel particles, prior to interaction with the DNA drops, would provide us with 294 
information about the maximum haemolytic response expected for these conditions. As regards the 295 
different incubation times, it was expected that the haemolytic response to the protein solutions 296 
would not alter over time. However, long incubation periods could affect the stability of the protein-297 
DNA gel particles, promoting the release of the protein into the solution and altering the haemolytic 298 
response.  299 
[Fig. 1 here] 300 
Studies of the different protein systems in solution demonstrated that the haemolytic response was 301 
weakly dependent on the protein composition in which particle formation took place (Fig. 1A). The 302 
obtained profiles showed haemolytic percentages that remained constant between 10 and 120 303 
min, increasing by only 5% by the end of the experiment (360 min). Note that the protein 304 
concentrations assayed in these studies (60 mM, concentrations ranged between 3x 104 and 2x 305 
105 µg mL-1 in the case of pure protein systems) were well above the 2x103 µg mL-1 assayed in the 306 
case of pure protein systems in solution (see above). Our results demonstrated that both of the 307 
pure proteins, LS and PS, as well as the mixtures at the imposed compositions (see Table 1) were 308 
non-haemolytic in nature.  309 
Individual protein-DNA gel particles incubated in the erythrocyte dispersion for periods of time 310 
ranging between 10 and 360 min demonstrated no time-dependence in the haemolysis response. 311 
In all cases, the percentages of haemolysis were lower than 3% (Fig. 1B).   312 
Relationship between the degree of haemolysis, number of erythrocytes and agglutination 313 
of erythrocytes 314 













Determination of haemolytic properties is one of the most common tests in studies of particle 315 
interaction with blood components. Interpreting the results of these studies is complicated due to 316 
variability in experimental approaches and a lack of universally accepted criteria for determining 317 
the test-result validity. Most in vitro studies of particle-induced haemolysis evaluate the percentage 318 
of haemolysis by spectrophotometrically detecting plasma-free haemoglobin derivatives after 319 
incubating the particles with blood and then separating undamaged cells by centrifugation. 320 
However, some particle interference due to haemoglobin precipitates adsorbed with the particles 321 
on centrifugation has been reported, yielding a false negative result (Dobrovolskaia et al., 2008). 322 
To avoid these false negative results in the haemolytic response of these protein-DNA particles, 323 
the evolution of both haemolytic activity and the number of erythrocytes in the dispersions for each 324 
time were determined simultaneously. Fig. 2A shows the results. There is a good relationship 325 
between the degree of haemolysis found and the number of erythrocytes. Low values of 326 
haemolytic responses correspond to a high number of erythrocytes in the corresponding 327 
dispersion; and an increase in haemolysis corresponds to a decrease in the number of 328 
erythrocytes. Thus, the effect of adsorbed haemoglobin on the particles can be considered 329 
negligible.  330 
There is, however, another point to be not . Starting for systems containing equimolar amount of 331 
both proteins or higher PS content, a strong decrease of the number of erythrocytes was observed, 332 
even for the shortest incubation time. This decrease, corresponding to a half of the initial number of 333 
erythrocytes was independent of the haemolytic responses. This fact can be correlated with the 334 
agglutination of the erythrocytes, which became visible for the erythrocyte dispersions incubated 335 
with these systems (Fig. 2B). 336 
[Fig. 2 here] 337 
 338 
 Relationship between the DNA released and the degree of haemolysis 339 













Previous work in our lab has demonstrated the potential application of these protein-DNA gel 340 
particles in the controlled encapsulation and release of DNA (Morán et al., 2009a). The magnitude 341 
of the DNA release was controlled and controlled release systems were achieved by changing the 342 
LS/PS ratio in the protein solution where particles were formed. 343 
Nevertheless, it was of major interest in this study to characterise these DNA gel particles, 344 
considering their kinetics of DNA release and the induced haemolytic response simultaneously. 345 
The release profiles of DNA from the protein-DNA gel particles in PBS buffer (pH 7.4) prepared 346 
with different protein compositions were monitored simultaneously with the haemolysis response 347 
induced by these protein-DNA gel particles in the same buffer solution.  348 
The values for both the amount of DNA release and the percentage of haemolysis for each 349 
composition after 360 min of incubation have been plotted in Fig. 3. It can be seen that the amount 350 
of DNA released, for an almost constant haemolytic response, was strongly dependent on the 351 
protein composition in which particle formation took place. In the range of LS/PS studied, the 352 
amount of DNA that was released varied from 100 µg mL-1 in the case of the pure LS system to  3 353 
µg mL-1 in the systems containing the PS protein. Further studies demonstrated that intermediate 354 
compositions between the pure LS system and the LSPS15 system promoted a more progressive 355 
decrease in DNA release with a similar haemolytic response (Fig. 3B). 356 
[Fig. 3 here] 357 
 358 
Determination of protein content and complexation stoichiometries  359 
The observed differences in DNA release can be explained by differences in protein-DNA 360 
complexation in these systems. To this end, the amount of protein released in the media by the 361 
end of the experiment was determined (Fig. 4, black bars). The protein:DNA ratio in the particles 362 
was determined from the protein released by the particles and the amount of DNA released into 363 
the media (see Fig. 3 line plots and Fig. 4, grey bars). Fig. 4A shows the evolution of the 364 
protein:DNA ratio according to protein composition.  365 













This protein-DNA ratio increased strongly from the pure LS system to the pure PS system. This 366 
different distribution can be correlated with differences in the gelation process during particle 367 
formation. It was expected that a homogeneous gelation would give rise to homogeneous 368 
structures (solid particle) whereas a more inhomogeneous gelation process would form core-shell 369 
particles (Morán et al., 2010). 370 
In the present study, the stoichiometries obtained corroborated that the presence of PS favoured 371 
the formation of solid particles. This model was supported by visual inspection, in which translucent 372 
and opaque/condensed particles were obtained (Fig. 4B).  373 
[Fig. 4 here] 374 
3.1.2.2. Protein-DNA gel particles prepared by the nebulisation method 375 
In previous studies in our lab, we have prepared nano-/micro-sized DNA gel particles by 376 
nebulisation of DNA solutions (either single- (ssDNA) or double-stranded (dsDNA)) into an 377 
oppositely charged surfactant or protein solution (Morán et al., 2009b).  The size and size 378 
distribution of the particle populations were investigated by means of fluorescence microscopy 379 
(FM), photon correlation spectroscopy (PCS) and scanning electron microscopy (SEM). FM studies 380 
suggest that the formation of the particles was carried out with conservation of the secondary 381 
structure of the nucleic acid molecules. SEM on freeze-dried and Au-shadowed samples showed a 382 
distribution of virtually spherical particles. Although the particle suspensions were investigated 383 
without further purification it was found that, in addition to the size of the initial DNA droplets, the 384 
cationic agent is a controlling parameter of the particle size. LS-DNA gel particles showed 385 
diameters around 10 µm whereas the size of PS-DNA was around 400 nm.  386 
 387 
In the present study, protein-DNA gel particles from mixed protein systems have been prepared by 388 
the nebulisation method for the first time. The assayed conditions correspond to a half of the 389 
previous studied concentrations (Morán et al., 2009b). Mixed protein-DNA particles prepared with 390 
proteins with very different molecular weight (LS with a molecular mass of 14.3 kDa and PS with a 391 













molecular mass of 5.1 kDa) made particularly difficult to use centrifugal concentrators with a 392 
suitable cut-off to efficiently remove both proteins. For this reason, these particle dispersions have 393 
been studied without further purification.  394 
The haemolytic activity of the protein-DNA gel particles prepared by the nebulisation method was 395 
determined. For thus, several volumes (100-300 µL) of the dispersions containing the protein-DNA 396 
gel particles were incubated in the erythrocyte dispersion for periods of time ranging between 10 397 
and 360 min and haemolysis was determined. The obtained results demonstrated no time-398 
dependence in the haemolysis response. In all cases, the percentages of haemolysis were lower 399 
than 1% (data not shown).   400 
The protein concentrations assayed in these studies (2.5 mM, concentrations ranged between 3x 401 
103 and 2x 104 µg mL-1 in the case of pure protein systems) were one order of magnitude lower 402 
than those assayed in the case of protein-DNA gel particles obtained by the dropwise addition 403 
method, where haemolytic responses were always lower than 3% (see Fig. 1B).  404 
 405 
3.2. Cytotoxic assessments 406 
Cytotoxicity plays a critical role in the efficiency of the delivery vectors. In order to deliver the DNA 407 
into the cells, the cationic particles bind to the cell surface by electrostatic interaction, promote 408 
endocytosis and release the genetic material inside the cell. Unfortunately, while high 409 
concentrations of the delivery agents imply an increased chance of the DNA penetrating the cell 410 
nucleus, they can also interfere with physiological processes within the cell, inducing cell death. 411 
Thus, present research is aimed at designing gene delivery agents that are able to deliver DNA 412 
into the cells with minimal toxicity (Rao et al., 2007).   413 
3.2.1.Cytotoxicy induced by proteins in solution 414 
Assessing the capacity of live cells to metabolise a tetrazolium colourless salt to a blue formazan 415 
(MTT assay) is one of the most common methods used to perform indirect measurements of cell 416 
viability. Dose–response curves for each protein, determined by MTT assays using tumour cell line 417 













HeLa and non-tumour cell line 3T3 fibroblasts, are given in Fig. 5. The cytotoxicity assays were 418 
performed in the concentration range 50 and 2000 μg mL-1. Although it is thought that proteins are 419 
biocompatible and nontoxic compounds, our results have revealed that, as with other cationic 420 
derivatives, LS and PS displayed concentration-dependent toxicity towards cells in vitro. LS 421 
showed low cytotoxicity towards 3T3 cells, which displayed viability in the range 81% to 100% as 422 
determined by the MTT assay (Fig. 5A) at the tested protein concentration range. In the case of 423 
PS, viability changed from 7% to 100% according to the concentration. The corresponding IC50 424 
values were 140 µg mL-1 and >2000 µg mL-1 for PS and LS, respectively.  425 
Analogous studies were carried out with the tumour cell line HeLa. The response to these two 426 
proteins was very similar to that of the 3T3 cell line, as can be seen in Fig. 5B. The corresponding 427 
IC50 values were 250 µg mL
-1 and >2000 µg mL-1 for PS and LS, respectively. 428 
[Fig. 5 here] 429 
3.2.2. Cytotoxicity in vitro induced by protein-DNA gel particles  430 
3.2.2.1. Protein-DNA gel particles prepared by the dropwise addition method 431 
It was of great interest in this study to characterise these DNA gel particles considering the 432 
cytotoxic response they induced. Fig. 6 shows the cytotoxic response of 3T3 and HeLa cell lines 433 
treated with both the protein-DNA gel particles and the corresponding protein solutions, determined 434 
by MTT assay. Cell viabilities of up to 80% were observed in almost all compositions when the 435 
cytotoxicity of the corresponding protein-DNA gel particles was determined in both cell lines (Fig. 436 
6A). However, relative viabilities were always lower than 10% when 3T3 cells were incubated in 437 
the presence of pure and mixed protein systems. Similar results were obtained for the HeLa cell 438 
line. In this case, cell viabilities increased step-wise to 20% (Fig. 5B).  439 
 [Fig. 6 here] 440 
 441 
3.2.2.2. Protein-DNA gel particles prepared by the nebulisation method 442 













Although the molecular details of the mechanism by which cationic carriers mediate DNA delivery 443 
are still poorly understood, current evidence supports the hypothesis that cationic lipid-DNA 444 
complexes enter cells by means of endocytosis. Often, the particle size ranges from 100 nm to 445 
over 1 µM, and evidently, the efficiency of cellular uptake and subsequent intracellular processing, 446 
may depend on particle size (Rejman et al., 2004). 447 
Using the MTT assay, the cytotoxic effect of these systems was determined. Fig. 7 shows the 448 
relative cytotoxicity of the protein-DNA gel particles and the corresponding protein solutions 449 
towards the 3T3 and HeLa cell lines. In both cases, the assayed concentration was 1.25 mM, 450 
expressed in terms of protein concentration. Note that the LSPS7.5 composition has been also 451 
included; considering the results obtained in the haemolysis vs. DNA release section (see Fig. 3B). 452 
From Fig. 7A it can be deduced that 3T3 cells exhibited cell viabilities that can be modulated from 453 
10 to 70% according to the protein composition in the protein-DNA gel particles. It is interesting to 454 
note that the presence of a small quantity of PS produced a marked improvement in cell viability 455 
compared to the pure LS system, and a small proportion of LS in the PS system produced a 456 
marked reduction in the cell viability obtained in comparison with pure PS. A parallel trend was 457 
observed when the cytotoxicity of these systems was assayed with the HeLa cell line. However, 458 
relative viabilities of the 3T3 cell line were always higher than those observed in the case of the 459 
HeLa cell line, and the tumour cell line HeLa appeared to be more sensitive to the deleterious 460 
effects of the protein-based particles than 3T3 fibroblasts. 461 
In order to compare, the relative viabilities obtained with the corresponding protein solutions have 462 
also been plotted (Fig. 7B). Cell viability in the 3T3 cell line was strongly dependent on the protein 463 
composition, ranging from a maximum value of around 80% with pure LS to minimum values of 464 
around 10% for systems containing the PS protein.  465 
The observed differences in cytotoxicity may be correlated with differences in protein-DNA 466 
complexation in these systems. Consequently, we determined the initial amount of protein in the 467 
media, as well as the amount of protein remaining in the dispersion containing the protein-DNA gel 468 













particles formed by the nebulisation method. From these values, the degree of complexation in the 469 
different systems was determined. Fig. 7C shows the evolution of the degree of complexation 470 
according to the LS/PS ratio. In the case of the protein-DNA gel particles, it was expected that the 471 
higher the degree of complexation, the smaller the amount of protein that would be released in 472 
solution, an amount which would be able to interact with the cells and reduce their viability. 473 
Independently of the cell line response, the differences in the degree of complexation were in 474 
agreement with the observed trend in cell viabilities (Fig. 7D). 475 
[Fig. 7 here] 476 
Relative viabilities of tumour and non-tumour cell lines 477 
Further data on the concentration-dependent cytotoxicity of these small-sized protein-DNA gel 478 
particles was obtained by examination of the relative cytotoxicity of several dilutions of the 479 
corresponding dispersions (Fig. 8). Note that the concentrations are expressed in terms of protein 480 
concentration, given in mM. The highest concentration corresponded to the conditions shown in 481 
Fig. 7A. By fitting the curves in Fig. 8, it was possible to determine the IC50 of these protein-based 482 
DNA carriers (Table 2).  483 
 [Fig. 8 here] 484 
[Table 2 here] 485 
 486 
It can be seen from the IC50-values that the two cells lines showed markedly different sensitivity to 487 
the cytotoxic effects of these small-sized protein-DNA particles. Except in the case of the pure 488 
systems, which displayed identical cytotoxicity in both cell lines, the tumour cell line HeLa 489 
appeared to be more sensitive to the deleterious effects of the mixed protein-based particles than 490 
3T3 fibroblasts (significant differences between 3T3 and HeLa for the same conditions are 491 
indicated in Table 2 with an asterisk).  492 
Internalisation of AO-labeled PS-DNA gel particles  493 
The ability of these particles to effectively cross biological barriers, which would allow their use in 494 
the delivery of DNA, was evaluated. PS-DNA gel particles, which showed both suitable particle 495 













size and minimum cytotoxic responses, were chosen for this kind of experiments. For this purpose, 496 
AO-labeled PS-DNA gel particles were prepared and the particle uptake by HeLa cells was 497 
assayed.  In general, particles exposed to cells in the absence of serum have a stronger adhesion 498 
to the cell membrane and higher internalization efficiency, in comparison to what is observed in 499 
medium containing serum, when a preformed protein layer is present on their surface (Lesniak et 500 
al., 2012). In order to perform these studies on the most favourable conditions the experiments 501 
were carried in absence of serum. Preliminary studies on cellular uptake of protein DNA gel 502 
particles prepared with DNA solutions in the presence of the nucleic acid selective dye acridine 503 
orange demonstrated that these particles could be internalised by HeLa cells (Fig. 9D).  504 
[Fig. 9 here] 505 
 506 
4. Discussion 507 
A general understanding of the interaction of DNA with oppositely charged amphiphiles and 508 
polyelectrolytes provides a basis for developing novel DNA gel particles, including protein-DNA gel 509 
particles. When used as DNA carriers, understanding the interactions of these DNA gel particles 510 
with red blood cells and established cells in vitro is crucial for improving their behaviour in vivo. To 511 
this end, we examined this interaction by using erythrocytes as a model of a biological membrane 512 
system.  Firstly, the haemolytic activity of these two proteins in solution was studied according to 513 
their concentration and the conc ntration-dependent curves were determined. It may be concluded 514 
that both proteins are non-haemolysing agents at the highest concentration assayed                          515 
(2000 µg mL-1).  516 
One drawback of protein-DNA gel particles, in toxicological terms, is the need for a cationic protein, 517 
which may cause some cell damage. Our results demonstrated that both of the pure proteins, LS 518 
and PS, as well as the mixtures at the imposed compositions (see Table 1) at which particles were 519 
prepared, were non-haemolytic in nature. Studies of individual protein-DNA gel particles incubated 520 
in the erythrocyte dispersion over periods of time ranging between 10 and 360 min demonstrated 521 













no time-dependence in the haemolysis response (Fig. 1). In all cases, the percentages of 522 
haemolysis were lower than the permissible 5% ((Rao et Sharma, 1997; Lv et al., 2007; He et al., 523 
2009; Verkatesan et al., 2011). Similar results were obtained with protein-DNA gel particles 524 
obtained by the nebulisation method. Consequently, the in vitro haemolysis results suggest that 525 
these protein-DNA gel particles show promise as long-term blood-contacting medical devices for 526 
several applications. 527 
The agglutination induced by the protein-DNA gel particles containing equimolar amount of both 528 
proteins or higher PS content (Fig. 2) may be caused by increased binding of the particles to the 529 
erythrocyte membrane, which might deformed cells and hence decrease the repulsion among them 530 
(Li et al., 2008). This behaviour could be attributed to differences in the binding characteristics of 531 
these two proteins, with different total charge and linear charge density: LS is a globular protein 532 
that has a net charge of + 9 at neutral pH, whereas PS is a highly positively charged linear protein 533 
with an overall charge of +21. 534 
It was of major interest in this investigation to characterise these DNA gel particles considering 535 
their kinetics of DNA release and the induced haemolytic response simultaneously (Fig. 3). It was 536 
observed that the amount of DNA released, for an almost constant haemolytic response, was 537 
strongly dependent on the protein composition at which particle formation took place. In the range 538 
of LS/PS studied, the amount of DNA that was released varied considerably, from 100 µg mL-1 in 539 
the case of the pure LS system to almost 3 µg mL-1 in the presence of the PS protein. Achieving 540 
high incorporation efficiencies and control over release kinetics present significant challenges in 541 
the development of a novel nonviral vector for gene therapy. Previous studies (Morán et al., 2009a) 542 
demonstrated, however, that LS-DNA particles exhibited initial fast burst release behaviour through 543 
a dissolution mechanism, without protecting the DNA secondary structure. However, the 544 
magnitude of DNA release was controlled and controlled release systems were achieved by 545 
changing the LS/PS ratio in the protein solution where particles were formed. The observed 546 
differences in DNA release can be explained by differences in protein-DNA complexation in these 547 
systems. As shown in Fig. 4, the protein-DNA ratio increased strongly from the pure LS system to 548 













the pure PS system. The stoichiometries obtained would appear to confirm that the presence of PS 549 
favours the formation of solid particles.  550 
Although proteins are thought to be biocompatible and nontoxic-compounds, the results of our 551 
safety evaluation with the established 3T3 and HeLa cell lines indicated that, as with other cationic 552 
derivatives, LS and PS displayed concentration-dependent toxicity towards cells in vitro (Fig. 5). In 553 
these experiments, cytotoxicity was determined in the presence of a range of protein 554 
concentrations, enabling us to define the protein concentration required to inhibit cell growth by 555 
50% compared with an untreated control (IC50). In the case of LS, its IC50 was found to be higher 556 
than 2000 µg mL-1 in both cell lines. For PS, it was found to be 140 and 250 µg mL-1 for 3T3 and 557 
HeLa cell lines, respectively. These differences could be attributed to differences in the binding 558 
characteristics of these two proteins, with different total charge and linear charge density: LS is a 559 
globular protein that has a net charge of + 9 at neutral pH, whereas PS is a highly positively 560 
charged linear protein with an overall charge of +21. 561 
Cell culture studies have greatly increased the understanding of cellular functions and complex 562 
signalling pathways and have been routinely used for toxicity screening of new compounds. All cell 563 
culture studies hinge on the capacity to maintain a suitable cell culture environment. However, 564 
these protocols may be altered by the presence of particles. Previous studies in our laboratory 565 
have verified the absorption of the culture media by the particles when 3T3 and Hela cell lines 566 
were incubated in the presence of some surfactant-DNA gel particles prepared by the dropwise 567 
addition method. In this case, the obtained cell viabilities were close to 5% (results not published). 568 
Although the IC50 values of the corresponding surfactants in solution were not very high (with 569 
values around 10 µg mL-1), this low cell viability may be correlated with the physicochemical 570 
properties of these DNA gel particles. Their swelling behaviour could restrict the optimal nutrition 571 
and physiological parameters to support the growth of cells.  572 
In was of great interest in this study to characterise these protein-DNA gel particles considering the 573 
cytotoxic response they induced. Visual inspection of the corresponding plates exhibited no evident 574 













changes on the volume and characteristics of the culture media when 3T3 and HeLa were 575 
incubated in the presence of individual protein-DNA gel particles during 24h. Although these 576 
particles are several magnitudes larger than cells and cannot be internalized as a whole, this study 577 
demonstrates that the physicochemical properties of these protein-DNA gel particles may not affect 578 
their cytotoxic characterization under standard protocols. These protein-DNA gel particles showed 579 
cell viabilities higher than 80% in almost all cases, except in the case of cells incubated in the 580 
presence of LSPS85-DNA gel particles (Fig. 6A). These results can be correlated with differences 581 
in protein content on these particles, as have been evaluated using the method of Bradford (Fig.  582 
4A). Although the protein-DNA gel particles remain visible on the plates after 24h of incubation, the 583 
total protein content on LSPS85-DNA gel particles (413 µg mL-1 of protein) in comparison with 584 
comparing with the other systems (amount ranged between 37 and 288 µg mL-1 of protein) might 585 
explain these differences in protein-induced cytotoxicity from protein-DNA gel particles. Significant 586 
differences between the cell viability obtained in the presence of protein-DNA gel particles and the 587 
corresponding proteins solutions have been obtained (Fig. 6B). 588 
In this study, small-sized mixed protein-DNA gel particles were prepared for the first time, and their 589 
cytotoxicity was evaluated. Although the particle dispersions were studied without further 590 
purification, and both free protein and protein-DNA gel particles were present in the obtained 591 
dispersions, the cytotoxic responses shown in Fig. 7A were observed to be significantly different to 592 
that observed with proteins in solution (Fig. 7B).  593 
This behaviour can be correlated with the capacity of the different protein systems to form weaker 594 
or stronger protein-DNA complexes. In the case of the protein-DNA gel particles, it was expected 595 
that the higher the degree of complexation, the smaller the amount of protein that would be 596 
released in solution, an amount which would be able to interact with the cells and reduce their 597 
viability. Determination of the degree of complexation in the different systems showed that it was 598 
strongly dependent on the protein composition at which particle formation took place (Fig. 7C). 599 
Independently of the cell line, the observed trend in cell viabilities was in agreement with the 600 
observed degree of complexation (Fig. 7D). 601 













The observed differences in cytotoxicity between protein-DNA particles prepared by the dropwise 602 
addition method and the nebulisation method could be related to differences in the kinetics of 603 
dissolution/release profiles. Studies of DNA release from protein-DNA particles formed by the 604 
dropwise addition method have demonstrated that these particles can present DNA release 605 
profiles of up to 1000 h, confirming the stability of these protein-DNA gel particles (Morán et al., 606 
2009a). In the present study, the stability of these particles in the culture medium was also 607 
confirmed. Supported by visual observation, the particles remained present in the well plate after 608 
24h of incubation. This behaviour and the fact that the observed cytotoxicity was almost 609 
independent of the protein composition (see Fig. 6A) corroborate this argument. Although the 610 
profiles of dissolution/release of the protein-DNA gel particles prepared by the nebulisation method 611 
have not yet been determined, it is expected that smaller particles will show faster dissolution 612 
profiles. As a consequence of the protein release, a more composition-dependent cytotoxic 613 
response compared with that observed at large-sized particles could be awaited. In the case of 614 
these small-sized protein-DNA particles the cytotoxic responses were strongly dependent on the 615 
protein composition (see Fig. 7A).   616 
The preparation of the protein-DNA gel particles by the nebulisation method enabled us to obtain 617 
particle dispersions in order to evaluate the effect of the concentration (in this study, expressed as 618 
protein concentration). Observation of IC50-values showed that the two cells lines were markedly 619 
different in sensitivity to the cytotoxic effects of these protein-DNA particles (Fig. 8 and Table 2). 620 
Except in the case of the pure systems, which displayed identical cytotoxicity in both cell lines, the 621 
tumour cell line HeLa was more sensitive to the deleterious effects of the mixed protein-based 622 
particles than 3T3 fibroblasts (significant differences between 3T3 and HeLa for the same 623 
conditions are indicated in Table 2 with an asterisk). Consequently, the mixing procedure had a 624 
clear modulating effect on the relative cytotoxicity of these systems towards tumour and non-625 
tumour cell lines.  626 
The ability of protein-DNA gel particles to effectively cross biological barriers was evaluated. To 627 
this end, PS-DNA particle dispersions were prepared by nebulisation of DNA containing the nucleic 628 













acid selective dye acridine orange. After formation, the particle dispersions were filtered by 629 
centrifugal concentrators to remove the excess of protein as well as the non-incorporated dye. 630 
Although using this procedure some leaking of the dye from the protein-DNA gel particle can be 631 
observed, which may permeate through the cell membrane and associate with genomic DNA, to 632 
fluoresce, clear differences between the stained HeLa cell controls and the cells exposed to AO-633 
labeled PS-DNA gel particles (Fig. 9B and 9D, respectively). These preliminary results indicate 634 
cellular uptake and internalisation of these protein-DNA particles, a prerequisite for subsequent 635 
DNA delivery.  636 
5. Concluding remarks 637 
Mixtures of two cationic proteins, lysozyme (LS) and protamine sulphate (PS) were used to 638 
prepare protein-DNA gel particles employing associative phase separation and interfacial diffusion. 639 
Protein-DNA gel particles prepared by both methods (dropwise addition and nebulisation) were 640 
demonstrated to be promising long-term blood-contacting medical devices based on their 641 
negligible haemolytic effect. Cytotoxicity studies demonstrated that the protein solutions at the 642 
concentration at which particles were prepared induced poor viabilities in 3T3 and HeLa cell lines. 643 
However, cytotoxicity towards 3T3 and HeLa cell lines was reduced significantly when 644 
administered in the protein-DNA gel particles prepared by dropwise addition method, with cell 645 
viabilities higher than 80%. In contrast, the cytotoxic responses induced by small-sized protein-646 
DNA gel particles were strongly dependent on the protein composition, with viabilities ranging 647 
between 10% and 70%. Under these conditions, the tumour cell line HeLa was more sensitive to 648 
the deleterious effects of the mixed protein-based particles than 3T3 fibroblasts. Preliminary results 649 
indicate cellular uptake and internalisation of these protein-DNA particles, a prerequisite for 650 
subsequent DNA delivery. 651 
Several points are of interest in these protein-DNA gel particles: firstly, unlike delivery in an 652 
aqueous solution, the cytotoxicity of the protein system can be reduced when the opposite charges 653 
between proteins and DNA spontaneously result in complexation due to electrostatic interactions. 654 













Secondly, the magnitude of DNA entrapment can be controlled and controlled release systems 655 
achieved through the formation of a DNA-protein complex network giving rise to these protein-DNA 656 
gel particles. The decrease in cytotoxicity as well as the formation of a releasable high DNA 657 
content reservoir renders these protein-DNA gel particles promising protein-based DNA vehicles 658 
for use as a nonviral gene delivery system. Current research focuses on the preparation of protein-659 
DNA gel particles using plasmid DNA. Further research on the particle uptake mechanism and the 660 
kinetics of drug uptake and retention in the different cell lines will be useful to establish the efficacy 661 
of these protein-DNA gel particles for various therapeutic applications. 662 
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FIGURE CAPTIONS 791 
 792 
Fig. 1. Protein solutions (A) and protein-DNA gel particles (B) induced haemoglobin release from 793 
rat erythrocytes as a function of time.  794 
Fig. 2. Time-course of the haemolytic response and the number of erythrocytes in the dispersions 795 
(A) and agglutination of rat erythrocytes observed by optical microscopy after 60 min of incubation 796 
with the protein-DNA gel particles (B).  797 
Fig. 3. Protein-DNA particle-induced haemoglobin release from rat erythrocytes and DNA release 798 
after 360 min of incubation (A) and kinetics of DNA release profiles for the studied protein-DNA 799 
particles.  800 
Fig. 4. Complexation stoichiometries of the protein-DNA gel particles according to the protein 801 
composition (A). Detailed images of the corresponding protein-DNA gel particles (B) (Adapted from 802 
Morán et al., 2009a). 803 
Fig. 5. Concentration-dependent relative viabilities of 3T3 cells (A) and HeLa cells (B) treated with 804 
LS and PS for 24 h determined by MTT assay. The data correspond to the average of three 805 
independent experiments ± standard deviation.  806 
Fig. 6. Relative viabilities of 3T3 and HeLa cells treated with individual protein-DNA gel particles 807 
(A) and the corresponding protein solutions (B) for 24 h, determined by MTT assay. The data 808 
correspond to the average of three independent experiments ± standard deviation. In all cases, 809 
significant differences (p<0.05) between 3T3 and HeLa for the same conditions were found. 810 
*Significantly different (p<0.05) from the corresponding protein solution. 811 
Fig. 7. Relative viabilities of 3T3 and HeLa cell lines treated with the protein-DNA gel particles 812 
dispersion (A) and the corresponding protein solutions (B) for 24 h, determined by MTT assay. In 813 
both cases, the assayed concentration was 1.25 mM, expressed in terms of protein concentration. 814 
The data correspond to the average of three independent experiments ± standard deviation. * 815 
Significantly different (p<0.05) from the corresponding protein solution. (C) Complexation 816 
stoichiometries of the protein-DNA gel particles according to the protein composition. (D) 817 













Comparison between the complexation stoichiometries of the protein-DNA gel particles and the 818 
relative viabilites of 3T3 and HeLa cell lines according to protein composition. 819 
Fig. 8. Concentration-dependent relative viabilities of 3T3 (A) and HeLa cells (B) treated with the 820 
protein-DNA gel particles prepared by the nebulisation method for 24 h, determined by MTT assay. 821 
The data correspond to the average of three independent experiments ± standard deviation. 822 
Fig. 9. Representative contrast microscopy images (A) and fluorescence images (B) of HeLa 823 
control. Contrast microscopy (C) and fluorescence images (D) of HeLa cells incubated during 2h in 824 
the presence of PS-DNA particles. 40X Magnification. 825 












Table 1. Composition (w/w) of the DNA carrier systems expressed as LS/PS ratio 
 






















Table 2. Cytotoxic properties of the protein-based DNA carrier systems prepared by 
the nebuliser method. Note that the IC50 values are given in terms of protein 







LS-DNA < 0.16 < 0.16 
LSPS7.5-DNA* > 1.25 0.88 
LSPS15-DNA > 1.25 0.92 
LSPS30-DNA* > 1.25 0.32 
LSPS50-DNA > 1.25 0.92 
LSPS70-DNA 0.80 0.60 
LSPS85-DNA* 0.75 0.68 
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Figure 9
